Galankin, Timofey L.
Kolbin, Alexey S.
Sidorenko, Sergey V.
Kurylev, Alexey A.
Malikova, Elena A.
Lobzin, Yuri V.
Ivanov, Dmitry O.
Shabalov, Nikolay P.
Mikhailov, Anton V.
Klimko, Nikolay N.
Dolgov, Gennadiy V.
Article History
Received: 22 January 2018
Accepted: 9 May 2018
First Online: 21 May 2018
Compliance with ethical standards
:
: Preliminary results of this study were published in a form of an abstract (European Association for Clinical Pharmacology and Therapeutics Congress in Prague, 2017):UnorderedList removed
: Alexey S. Kolbin participates in research and development with subsequent preparation of reports, writing articles and preparing presentations for the following companies (in alphabetical order): Allergen, Amgen, Astellas, Boehringer Ingelheim, Novartis, Novo Nordisk, Pfizer, Rosh, R-Pharma, and Sanofi-Aventis. None of these companies are involved in this study.The other co-authors confirm the absence of any conflict of interest which must be reported.
: The study was undertaken after obtaining approvals from the local ethics committees of all five centers where the medical data were collected:UnorderedList removed
: The data collection was retrospective, no special informed consent was needed, taking into account that any personal identifiers of the patients were removed from any study files. The standard consent to the processing of personal data signed by mothers on admission to hospital was considered sufficient by the local ethics committees.